Skip to main content

Table 1 Clinical Characteristics of 7 patients with CD (Prior EEN/Post EEN)

From: Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease

ID

Sex

Age

Montreal

Previous relevant medications

BMI (Pr*/Po*)

CDAI (Pr/Po)

ESR (mm/h) (Pr/Po)

CRP (mg/L) (Pr/Po)

ALB (g/L) (Pr/Po)

01

M

16

A1L3B1p

5-ASA/IFX

12.80/14.87

329.9/128.1

74/11

79.6/0.86

29.8/42.1

02

F

25

A2L2B1

Pred/5-ASA/IFX

17.19/17.97

250.87/107.89

35/2

7.67/0.86

33.1/44.6

03

F

31

A2L3B3p

5-ASA/IFX

16.41/18.75

257.44/118.24

23/18

7.38/0.86

35.3/38.3

04

M

23

A2L1B2

AZA/IFX

16.98/17.63

249.37/129.2

3/2

1.2/1.58

48.8/50.5

05

M

15

A1L1B1p

IFX

14.80/17.36

293.71/144.47

8/4

32.47/2.01

32.1/39.6

06

M

51

A3L3B3

5-ASA/IFX

20.43/20.70

385.8/108.47

5/4

16.4/0.78

24.7/32.8

07

M

34

A2L1B1

AZA/IFX

21.51/21.97

212.26/86.42

32.95/4

5.85/0.78

38.5/40.7

  1. CD Crohn’s disease, M male, F female, Pr Prior, Po Post, BMI body mess index, 5-ASA 5-aminosalicylic acid, IFX infliximab, Pred Prednisone, AZA Azathioprine, CDAI Crohn's disease activity index, ESR erythrocyte sedimentation rate, CRP C-reactive protein, ALB serum albumin
  2. *Pr represents the baseline collection time point and Po represents 8 weeks of EEN